Sunny joined Sofinnova BioEquities in June 2021 as an Analyst. He focuses on public investments in global medical technology, diagnostics, and life sciences tools companies.
Prior to Sofinnova, Sunny was an Associate Analyst at PFM Health Sciences, a hedge fund and crossover fund. Before PFM, Sunny worked in healthcare venture capital at Revelation Partners and BioAdvance. He began his career as a consultant at ZS Associates.
Sunny graduated from the University of Pennsylvania where he received his B.S. in Economics from the Wharton School along with a B.A. in Biology from the College of Arts & Sciences.